These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7748463)

  • 21. Pathways of the Maillard reaction under physiological conditions.
    Henning C; Glomb MA
    Glycoconj J; 2016 Aug; 33(4):499-512. PubMed ID: 27291759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychophysiological research in psychiatry and neuropsychopharmacology. II. The investigation of antihypoxidotic/nootropic drugs (tenilsetam and co-dergocrine-mesylate) in elderlies with the Viennese Psychophysiological Test-System (VPTS).
    Saletu B; Semlitsch HV; Anderer P; Resch F; Presslich O; Schuster P
    Methods Find Exp Clin Pharmacol; 1989 Jan; 11(1):43-55. PubMed ID: 2716439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycation vs. glycosylation: a tale of two different chemistries and biology in Alzheimer's disease.
    Taniguchi N; Takahashi M; Kizuka Y; Kitazume S; Shuvaev VV; Ookawara T; Furuta A
    Glycoconj J; 2016 Aug; 33(4):487-97. PubMed ID: 27325408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes.
    Yamagishi S; Nakamura N; Suematsu M; Kaseda K; Matsui T
    Mol Med; 2015 Oct; 21 Suppl 1(Suppl 1):S32-40. PubMed ID: 26605646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naturally occurring inhibitors against the formation of advanced glycation end-products.
    Peng X; Ma J; Chen F; Wang M
    Food Funct; 2011 Jun; 2(6):289-301. PubMed ID: 21779567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's disease--synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts.
    Münch G; Schinzel R; Loske C; Wong A; Durany N; Li JJ; Vlassara H; Smith MA; Perry G; Riederer P
    J Neural Transm (Vienna); 1998; 105(4-5):439-61. PubMed ID: 9720973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bimolecular interaction of argpyrimidine (a Maillard reaction product) in in vitro non-enzymatic protein glycation model and its potential role as an antiglycating agent.
    Bhattacherjee A; Dhara K; Chakraborti AS
    Int J Biol Macromol; 2017 Sep; 102():1274-1285. PubMed ID: 28487198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease.
    Münch G; Cunningham AM; Riederer P; Braak E
    Brain Res; 1998 Jun; 796(1-2):307-10. PubMed ID: 9689484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced glycation endproducts in food and their effects on health.
    Poulsen MW; Hedegaard RV; Andersen JM; de Courten B; Bügel S; Nielsen J; Skibsted LH; Dragsted LO
    Food Chem Toxicol; 2013 Oct; 60():10-37. PubMed ID: 23867544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased protein glycation in cerebrospinal fluid of Alzheimer's disease.
    Shuvaev VV; Laffont I; Serot JM; Fujii J; Taniguchi N; Siest G
    Neurobiol Aging; 2001; 22(3):397-402. PubMed ID: 11378244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Glycation and protein crosslinking in the diabetes and ageing pathogenesis].
    Cárdenas-León M; Díaz-Díaz E; Argüelles-Medina R; Sánchez-Canales P; Díaz-Sánchez V; Larrea F
    Rev Invest Clin; 2009; 61(6):505-20. PubMed ID: 20184132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intervention against the Maillard reaction in vivo.
    Monnier VM
    Arch Biochem Biophys; 2003 Nov; 419(1):1-15. PubMed ID: 14568003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary Advanced Glycation Endproducts Induce an Inflammatory Response in Human Macrophages in Vitro.
    van der Lugt T; Weseler AR; Gebbink WA; Vrolijk MF; Opperhuizen A; Bast A
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Maillard reaction inhibitors and their biological and therapeutic significance.
    Sztanke K; Pasternak K
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):156-8. PubMed ID: 15323184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced glycation end-products: Mechanics of aged collagen from molecule to tissue.
    Gautieri A; Passini FS; Silván U; Guizar-Sicairos M; Carimati G; Volpi P; Moretti M; Schoenhuber H; Redaelli A; Berli M; Snedeker JG
    Matrix Biol; 2017 May; 59():95-108. PubMed ID: 27616134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease.
    Rahmadi A; Steiner N; Münch G
    Clin Chem Lab Med; 2011 Mar; 49(3):385-91. PubMed ID: 21275816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alternative routes for the formation of immunochemically distinct advanced glycation end-products in vivo.
    Takeuchi M; Makita Z
    Curr Mol Med; 2001 Jul; 1(3):305-15. PubMed ID: 11899079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Troxerutin imparts preservative effects on albumin by preventing Maillard reaction-mediated early and advanced glycation modification.
    Awasthi S; Ravi A; Saraswathi NT
    J Biomol Struct Dyn; 2017 Sep; 35(12):2681-2687. PubMed ID: 27589094
    [No Abstract]   [Full Text] [Related]  

  • 39. Advanced Maillard reaction end products are associated with Alzheimer disease pathology.
    Smith MA; Taneda S; Richey PL; Miyata S; Yan SD; Stern D; Sayre LM; Monnier VM; Perry G
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5710-4. PubMed ID: 8202552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins.
    Sady C; Jiang CL; Chellan P; Madhun Z; Duve Y; Glomb MA; Nagaraj RH
    Biochim Biophys Acta; 2000 Sep; 1481(2):255-64. PubMed ID: 11018716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.